APOTHEEK TILIA: what changed
APOTHEEK TILIA
Largest movements
- Cash -€100,791
down €100,791 (-21.4%), from €471,634 to €370,843
mainly Contributions, distributions and other (-€118,135) and Other debts (-€86,925)
- Stocks and contracts +€35,231
up €35,231 (+9.9%), from €356,129 to €391,360
- Receivables within one year +€22,320
up €22,320 (+16.5%), from €134,974 to €157,294
of which Trade receivables: +€36,394
- Other debts -€86,925
down €86,925 (-42.4%), from €205,060 to €118,135
- Profit (loss) carried forward +€50,864
up €50,864 (+18.2%), from €279,093 to €329,957
- Tax, wage and social debts +€29,698
up €29,698 (+41.3%), from €71,993 to €101,691
of which Taxes: +€17,920
- Trade debts -€16,627
down €16,627 (-12.2%), from €135,947 to €119,320
- Gross operating margin +€134,937
up €134,937 (+22.5%), from €599,691 to €734,628
- Staff costs +€86,742
up €86,742 (+21.9%), from €396,099 to €482,841
- Taxes +€9,534
up €9,534 (+19.5%), from €48,787 to €58,321
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,039,355 | €1,016,365 | -€22,990 | -2.2% |
| Fixed assets | 21/28 | €69,671 | €79,914 | +€10,243 | +14.7% |
| Tangible fixed assets | 22/27 | €69,671 | €79,914 | +€10,243 | +14.7% |
| Plant, machinery and equipment | 23 | €69,671 | €79,914 | +€10,243 | +14.7% |
| Furniture and vehicles | 24 | €0 | - | = | |
| Current assets | 29/58 | €969,685 | €936,451 | -€33,234 | -3.4% |
| Amounts receivable after more than one year | 29 | €0 | - | = | |
| Other amounts receivable | 291 | €0 | - | = | |
| Stocks and contracts in progress | 3 | €356,129 | €391,360 | +€35,231 | +9.9% |
| Stocks | 30/36 | €356,129 | €391,360 | +€35,231 | +9.9% |
| Amounts receivable within one year | 40/41 | €134,974 | €157,294 | +€22,320 | +16.5% |
| Trade receivables | 40 | €120,900 | €157,294 | +€36,394 | +30.1% |
| Other amounts receivable | 41 | €14,074 | €0 | -€14,074 | -100% |
| Cash at bank and in hand | 54/58 | €471,634 | €370,843 | -€100,791 | -21.4% |
| Deferred charges and accrued income | 490/1 | €6,948 | €16,955 | +€10,007 | +144% |
| Total equity and liabilities | 10/49 | €1,039,355 | €1,016,365 | -€22,990 | -2.2% |
| Equity | 10/15 | €626,356 | €677,219 | +€50,864 | +8.1% |
| Contributions | 10/11 | €345,403 | €345,403 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €279,093 | €329,957 | +€50,864 | +18.2% |
| Amounts payable | 17/49 | €413,000 | €339,146 | -€73,854 | -17.9% |
| Amounts payable within one year | 42/48 | €413,000 | €339,146 | -€73,854 | -17.9% |
| Trade debts | 44 | €135,947 | €119,320 | -€16,627 | -12.2% |
| Suppliers | 440/4 | €135,947 | €119,320 | -€16,627 | -12.2% |
| Taxes, remuneration and social security | 45 | €71,993 | €101,691 | +€29,698 | +41.3% |
| Taxes | 450/3 | €4,770 | €22,691 | +€17,920 | +376% |
| Remuneration and social security | 454/9 | €67,223 | €79,000 | +€11,778 | +17.5% |
| Other amounts payable | 47/48 | €205,060 | €118,135 | -€86,925 | -42.4% |
| Remuneration, social security and pensions | 62 | €396,099 | €482,841 | +€86,742 | +21.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,230 | €16,856 | -€5,375 | -24.2% |
| Other operating charges | 640/8 | €423 | €799 | +€376 | +88.8% |
| Gross operating margin | 9900 | €599,691 | €734,628 | +€134,937 | +22.5% |
| Operating profit (loss) | 9901 | €180,938 | €234,132 | +€53,194 | +29.4% |
| Financial income | 75/76B | €1,566 | €3,639 | +€2,072 | +132% |
| Recurring financial income | 75 | €1,566 | €3,639 | +€2,072 | +132% |
| Financial charges | 65/66B | €9,731 | €10,451 | +€719 | +7.4% |
| Recurring financial charges | 65 | €9,731 | €10,451 | +€719 | +7.4% |
| Profit (loss) for the period before taxes | 9903 | €172,773 | €227,320 | +€54,547 | +31.6% |
| Income taxes | 67/77 | €48,787 | €58,321 | +€9,534 | +19.5% |
| Profit (loss) for the period | 9904 | €123,986 | €168,999 | +€45,013 | +36.3% |
| Profit (loss) for the period to be appropriated | 9905 | €123,986 | €168,999 | +€45,013 | +36.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.